Category: Pharmaceuticals
Avandia Clinical Trials Partially Stopped
Last week the Food and Drug Administration (FDA) advisory panel recommended that Avandia – a popular diabetes drug linked to a higher risk of heart attack – contain either stronger warning labels or restrict its use. Avandia is developed and manufactured by GlaxoSmithKline. In addition to a well-documented increased risk of heart attack, Avandia has… read more
Manufacturers of dangerous drugs should not be immune from liability
The Sixth Circuit Court of Appeals has recently submitted a question to the Food and Drug Administration requesting a response to its position on immunity. At issue is the claim by manufacturers that because the FDA regulates prescription drugs, once the drugs they make have received FDA “approval,” drug manufacturers cannot be held liable for… read more
AVANDIA RECENT NEWS
Please see our Avandia information page to learn about the most up-to-date news on the harmful diabetes drug. The attorneys and lawyers at the Branch Law Firm can help you take action against the pharmaceutical giant Glaxo Smith Kline, makers of the diabetes drug Avandia; also known as Rosiglitazone.
DANGEROUS DRUG – Reglan
Reglan is a prescription drug pushed by pharmaceutical companies to patients to treat Gastroesophageal reflux (GER) Gastroesophageal reflux disease (GERD). Many studies dating back from the 1970s have shown that Reglan is ineffective in resolving GER and GERD. A 2006 study published in Nature Clinical Practice: Gastroenterology & Hepatology concluded that “the evidence base for… read more
NEW MEXICO DANGEROUS DRUGS – AVANDIA RESEARCHERS TIED TO CONFLICTS OF INTERESTS
According to Bloomberg News, 94% of researchers who found positive results from using Avandia had financial ties to pharmaceutical companies. Avandia is a controversial diabetes drug that has been linked to increased sharp increased risk of heart attack and death. Despite the FDA’s issuance of a formal safety alert concerning the risks associated with Avandia,… read more
New Mexico Dangerous Drugs – FDA Conflicts of Interest Compromise Our Safety
Recent allegations of research collaboration between the FDA’s top drug official – Dr. Janet Woodcock – and a pharmaceutical company underscore the potential for conflicts of interests and the high stakes involved in drug marketing. In fact, over the years the FDA has been involved in many conflicts of interest involving dangerous drugs. In August… read more
New Mexico Dangerous Drugs – GlaxoSmithKline Has Duty To Warn Of Avandia Risks
The U.S. Senate Finance Committee has recently issued a report on Avandia, a controversial drug produced by GlaxoSmithKline (“GSK”) to control diabetes. According to the report, GSK knew of possible heart attack risks tied to Avandia many years before the information became public. The report unequivocally states “GSK had a duty to sufficiently warn patients… read more
New Mexico Dangerous Drugs – Wyeth v. Levine Should Apply To Generic Drugs
In a victory for consumers, last Friday the Fifth Circuit Court of Appeals agreed with the lower court that individuals may sue generic drug makers in state court for the “failure to warn” consumers of potentially dangerous side effects from taking their drugs. This decision shadows last March’s Supreme Court decision in Wyeth v. Levine,… read more